Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trialShiqi Li, Yujia Cai, Sikai Ling et al.|Cell stem cell|2024Cited by 77
Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell TransplantRuihao Huang, Xi Zhang, Jiang F. Zhong et al.|JAMA Oncology|2023Cited by 53
Abstract CT052: Clinical safety and efficacy study of TruUCAR™ GC027: The first-in-human, universal CAR-T therapy for adult relapsed/refractory T-cell acute lymphoblastic leukemia (r/r T-ALL)Xinxin Wang, Xi Zhang, Shiqi Li et al.|Cancer Research|2020Cited by 30
Efficacy and Safety of Hetrombopag Versus Thrombopoietin in Promoting Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Randomized Controlled Clinical TrialYimei Feng, Xi Zhang, Linhui Wang et al.|American Journal of Hematology|2025Cited by 5
Abstract LB147: Updates on clinical safety and efficacy result of GC027, the first-in-human, “Off-the-Shelf” CD7 CAR-T stand-alone therapy for adult patients with relapsed/refractory T-cell lymphoblastic leukemia (r/r T-ALL)Shiqi Li, Xi Zhang, Lei Gao et al.|Cancer Research|2021Cited by 4